Soy isoflavones, CYP1A1, CYP1B1, and COMT polymorphisms, and breast cancer: A case-control study in southwestern China

DNA and Cell Biology

Volumn 30, Issue 8, 2011, Pages 585-595

  Wang, Qiong ^a   Li, Hui ^b   Tao, Ping ^b   Wang, Yuan Ping ^a   Yuan, Ping ^a   Yang, Chun Xia ^a   Li, Jia Yuan ^a   Yang, Fei ^c   Lee, Hui ^a   Huang, Yuan ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^c Chengdu Municipal Center for Disease Control and Prevention   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL METHYLTRANSFERASE; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; ISOFLAVONE DERIVATIVE; LEUCINE; METHIONINE; SOY ISOFLAVONE; UNCLASSIFIED DRUG; VALINE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CHINA; CHINESE; COMT GENE; CONTROLLED STUDY; CYP 1A1 GENE; CYP 1B1 GENE; DIETARY INTAKE; FEMALE; GENE; GENE SEQUENCE; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOTE; HIGH RISK POPULATION; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT; SEQUENCE ANALYSIS;

ADULT; AGED; ARYL HYDROCARBON HYDROXYLASES; ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CATECHOL O-METHYLTRANSFERASE; CHINA; CYTOCHROME P-450 CYP1A1; DIET; ENERGY METABOLISM; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ISOFLAVONES; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; SOYBEANS;

EID: 79960945499     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2010.1195     Document Type: Article

References (55)

1. Adlercreutz, H., and Mazur, W. (1997).Phyto-oestrogens and western diseases. Ann Med 29, 95-120. (Pubitemid 27226319)
2. Akiyama, T., Ishida, J., Nakagawa, S., Ogawara, H., Watanabe, S., Itoh, N., Shibuya, M., and Fukami, Y. (1987).Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262, 5592-5595.
3. American Cancer Society. (2007).Global Cancer Facts And Figures 2007 (American Cancer Society, Atlanta).
4. Borrá s, C., Gambini, J., Gmez-Cabrera, M.C., Sastre, J., Pallardó , F.V., Mann, G.E., and Viñ a, J. (2006).Genistein, a soy isoflavone, up-regulates expression of antioxidant genes: involvement of estrogen receptors, ERK1/2, and NFkappaB. FASEB J 20, 2136-2138.
5. Boyapati, S.M., Shu, X.O., Gao, Y.T., Cai, Q., Jin, F., and Zheng, W. (2005).Polymorphisms in CYP1A1 and breast carcinoma risk in a population-based case-control study of Chinese women. Cancer 103, 2228-2235. (Pubitemid 40686565)
6. Bray, F., McCarron, P., and Parkin, D.M. (2004).The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res 6, 229-239. (Pubitemid 39440251)
7. Chan, H.Y., and Leung, L.K. (2003).A potential protective mechanism of soya isoflavones against 7,12-dimethylbenz[a]- anthracene tumour initiation. Br J Nutr 90, 457-465. (Pubitemid 36992549)
8. Crofts, F., Taioli, E., Trachman, J., Cosma, G.N., Currie,D., Toniolo, P., and Garte, S.J. (1994).Functional significance of different human CYP1A1 genotypes. Carcinogenesis 15, 2961-2963.
9. Curado, M.P., Edwards, B., Shin, H.R., Storm, H., Ferlay, J., Heanue, M., and Boyle, P. (2007).Cancer Incidence in Five Continents (IARC Scientific Publications, Lyon).
10. Dawling, S., Roodi, N., Mernaugh, R.L., Wang, X., and Parl, F.F. (2001).Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms. Cancer Res 61, 6716-6722. (Pubitemid 32896493)
11. Ding, H., Fu, Y., Chen, W.X., and Wang, Z.W. (2010).COMT Val158Met polymorphism and breast cancer risk: evidence from 26 case-control studies. Breast Cancer Res Treat 123, 265-270.
12. Dong, J.Y., and Qin, L. (2011).Soy isoflavones consumption and risk of breast cancer incidence or recurrence: a metaanalysis of prospective studies. Breast Cancer Res Treat 125, 315-323.
13. Economopoulos, K.P., and Sergentanis, T.N. (2010).Does race modify the association between CYP1B1 Val432Leu polymorphism and breast cancer risk? A critical appraisal of a recent meta-analysis. Breast Cancer Res Treat 124, 293-294 (abstract).
14. Fan, Y., Feng, Y.M., Wang, L.M., Wang, Y., and Fu, L. (2007). The relationship between catechol-o-methyltransferase (COMT) polymorphisms and the development of breast cancer. Chin J Clin Oncol 34, 430-433 (in Chinese).
15. Hamajima, N., Matsuo, K., Tajima, K., Mizutani, M., Iwata, H., Iwase, T., Miura, S., Oya, H., and Obata, Y. (2001).Limited association between a catechol-O-methyltransferase (COMT) polymorphism and breast cancer risk in Japan. Int J Clin Oncol 6, 13-18. (Pubitemid 32230357)
16. Hanna, I.H., Dawling, S., Roodi, N., Guengerich, F.P., and Parl, F.F. (2000).Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity. Cancer Res 60, 3440-3444. (Pubitemid 30482162)
17. Hirose, K., Imaeda, N., Tokudome, Y., Goto, C., Wakai, K., Matsuo, K., Ito, H., Toyama, T., Iwata, H., Tokudome, S., and Tajima, K. (2005).Soybean products and reduction of breast cancer risk: a case-control study in Japan. Br J Cancer 93, 15-22. (Pubitemid 41076247)
18. Huang, C.S., Chern, H.D., Chang, K.J., Cheng, C.W., Hsu, S.M., and Shen, C.Y. (1999).Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility. Cancer Res 59, 4870-4875.
19. Huang, C.S., Shen, C.Y., Chang, K.J., Hsu, S.M., and Chern, H.D. (1999).Cytochrome P4501A1 polymorphism as a susceptibility factor for breast cancer in postmenopausal Chinese women in Taiwan. Br J Cancer 80, 1838-1843.
20. IARC.( 2002).Cancer Epidemiology Database, GLOBOCAN 2002. Available at www-dep. iarc. fr/(Lyon).
21. IARC. (2008).Cancer Epidemiology Database, GLOBOCAN 2008. Available at www-dep. iarc. fr/(Lyon).
22. Jefcoate, C.R., Liehr, J., Santen, R.J., Sutter, T.R., Yager, J.D., Yue, W., Santner, S.J., Tekmal, R., Demers, L., Pauley, R., Naftolin, F., Mor, G., and Berstein, L. (2000).Tissue-specific synthesis and oxidative metabolism of estrogens. J Natl Cancer Inst Monogr 27, 95-112.
23. Jiao, H., Liu, C., Guo, W., Peng, L., Chen, Y., and Martin, F.L. (2010).Association of CYP1B1 polymorphisms with breast cancer: a case-control study in the han population in Ningxia Hui autonomous region, P. R. China. Biomark Insights 12, 21-27.
24. Kazi, A., Daniel, K.G., Smith, D.M., Kumar, N.B., and Dou, Q.P. (2003).Inhibition of the proteasome activity, a novel mechanism associated with the tumor cell apoptosis-inducing ability of genistein. Biochem Pharmacol 66, 965-976. (Pubitemid 37083593)
25. Lakhani, N.J., Sarkar, M.A., Venitz, J., and Figg, W.D. (2003).2- Methoxyestradiol, a promising anticancer agent. Pharmacotherapy 23, 165-172.
26. Larsen, M.C., Angus, W.G., Brake, P.B., Eltom, S.E., Sukow, K.A., and Jefcoate, C.R. (1998).Characterization of CYP1B1 and CYP1A1 expression in human mammary epithelial cells: role of the aryl hydrocarbon receptor in polycyclic aromatic hydrocarbon metabolism. Cancer Res 58, 2366-2374. (Pubitemid 28252696)
27. Lavigne, J.A., Takahashi, Y., Chandramouli, G.V., Liu, H., Perkins, .N., Hursting, S.D., and Wang, T.T. (2008).Concentrationdependent effects of genistein on global gene expression in MCF-7 breast cancer cells: an oligo microarray study. Breast Cancer Res Treat 110, 85-98. (Pubitemid 351793861)
28. Lee, K.M., Abel, J., Ko, Y., Harth, V., Park, W.Y., Seo, J.S., Yoo, K.Y., Choi, J.Y., Shin, A., Ahn, S.H., Noh, D.Y., Hirvonen, A., and Kang, D. (2003).Genetic polymorphisms of cytochrome P450 19 and 1B1, alcohol use, and breast cancer risk in Korean women. Br J Cancer 88, 675-678. (Pubitemid 36411442)
29. Lee, S.A., Shu, X.O., Li, H., Yang, G., Cai, H., Wen, W., Ji, B.T., Gao, J., Gao, Y.T., and Zheng, W. (2009).Adolescent and adult soy food intake and breast cancer risk: results from the Shanghai Women's Health Study. Am J Clin Nutr 89, 1920-1926.
30. Lehmann, L., Jiang, L., and Wagner, J. (2008).Soy isoflavones decrease the catechol-O-methyltransferase-mediated inactivation of 4-hydroxyestradiol in cultured MCF-7 cells. Carcinogenesis 29, 363-370. (Pubitemid 351359676)
31. Li, S.F., Li, J.Y., Lei, F.M., Li, H., Sun, G.R., Zhou, W.D., Tao, P., and Li, W.H. (2006).A case-control study on risk factors of breast cancer. Mod Prev Med 33, 2233-2235 (in Chinese).
32. Lin, W.Y., Chou, Y., Wu, M.H., Jeng, Y.L., Huang, H.B., You, S.L., Chu, T.Y., Chen, C.J., and Sun, C.A. (2005).Polymorphic catechol-O-methyltransferase gene, duration of estrogen exposure, and breast cancer risk: a nested case-control study in Taiwan. Cancer Detect Prev 29, 427-432. (Pubitemid 41406137)
33. Mao, C., Wang, X.W., Qiu, L.X., Liao, R.Y., Ding, H., and Chen, Q. (2010).Lack of association between catechol-O-methyltransferase Val108/158Met polymorphism and breast cancer risk: a meta-analysis of 25,627 cases and 34,222 controls. Breast Cancer Res Treat 121, 719-725.
34. McPherson, K., Steel, C., and Dixon, J.M. (2000).Breast cancerepidemiology, risk factors, and genetics. BMJ 321, 624-628.
35. Mitra, A.K., Faruque, F., and Avis, A.L. (2004).Breast cancer and environmental risks: where is the link? J Environ Health 66, 24-32. (Pubitemid 38327280)
36. Miyoshi, Y., Takahashi, Y., Egawa, C., and Noguchi, S. (2002). Breast cancer risk associated with CYP1A1 genetic polymorphisms in Japanese women. Breast J 8, 209-215. (Pubitemid 34810580)
37. Ng, D.P., Tan, K.W., Zhao, B., and Seow, A. (2005).CYP1A1 polymorphisms and risk of lung cancer in non-smoking Chinese women: influence of environmental tobacco smoke exposure and GSTM1/T1 genetic variation. Cancer Causes Control 16, 399-405. (Pubitemid 40897832)
38. Park, K., Choi, K., Kim, H., Kim, K., Lee, M.H., Lee, J.H., and Kim Rim, J.C. (2009).Isoflavone-deprived soy peptide suppresses mammary tumorigenesis by inducing apoptosis. Exp Mol Med 41, 371-381.
39. Parkin, D.M., Whelan, S.I., Ferlay, J., Raymond, L., and Young, J. (1997).Cancer Incidence in Five Continents. (IARC Scientific Publications, Lyon).
40. Parkin, D.M., Whelan, S.I., Ferlay, J., Teppo, L., and Thomas, D.B. (2002).Cancer Incidence in Five Continents. (IARC Scientific Publications, Lyon).
41. Roberts, D.W., Doerge, D.R., Churchwell, M.I., Gamboa da Costa, G., Marques, M.M., and Tolleson, W.H. (2004).Inhibition of extrahepatic human cytochromes P450 1A1 and 1B1 by metabolism of isoflavones found in Trifolium pratense (red clover).J Agric Food Chem 52, 6623-6632.
42. Ryan-Borchers, T.A., Park, J., Chew, B.P., McGuire, M.K., Fournier, L.R., and Beerman, K.A. (2006).Soy isoflavones modulate immune function in healthy postmenopausal women. Am J Clin Nutr 83, 1118-1125.
43. Sazci, A., Ergul, E., Utkan, N.Z., Canturk, N.Z., and Kaya, G. (2004).Catechol-O-methyltransferase Val 108/158 Met polymorphism in premenopausal breast cancer patients. Toxicology 204, 197-202. (Pubitemid 39244079)
44. Sergentanis, T.N., and Economopoulos, K.P. (2010).Four polymorphisms in cytochrome P450 1A1 (CYP1A1) gene and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 122, 459-469.
45. Shin, A., Kang, D., Choi, J.Y., Lee, K.M., Park, S.K., Noh, D.Y., Ahn, S.H., and Yoo, K.Y. (2007).Cytochrome P450 1A1 (CYP1A1) polymorphisms and breast cancer risk in Korean women. Exp Mol Med 39, 361-366. (Pubitemid 47037627)
46. Tan, W, Qi, J., Xing, D.Y., Miao, X.P., Pan, K.F., Zhang, L., and Lin, D.X. (2003).Relation between single nucleotide polymorphism in estrogen-metabolizing genes COMT, CYP17 and breast cancer risk among Chinese women. Zhonghua Zhong Liu Za Zhi 25, 453-456 (in Chinese).
47. Thompson, P.T., and Ambrosone, C. (2000).Molecular epidemiology of genetic polymorphisms in estrogen metabolizing enzymes in human breast cancer. J Natl Cancer Inst Monogr 27, 125-134.
48. Trock, B.J., Hilakivi-Clarke, L., and Clarke, R. (2006).Metaanalysis of soy intake and breast cancer risk. J Natl Cancer Inst Monogr 98, 459-471.
49. Vineis, P., and McMichael, A. (1996).Interplay between heterocyclic amines in cooked meat and metabolic phenotype in the etiology of colon cancer. Cancer Causes Control 7, 479-486. (Pubitemid 26228338)
50. Watanabe, J., Shimada, T., Gillam, E.M., Ikuta, T., Suemasu, K., Higashi, Y., Gotoh, O., and Kawajiri, K. (2000).Association of CYP1B1 genetic polymorphism with incidence to breast and lung cancer. Pharmacogenetics 10, 25-33. (Pubitemid 30142810)
51. Wen, W., Cai, Q., Shu, X.O., Cheng, J.R., Parl, F., Pierce, L., Gao, Y.T., and Zheng, W. (2005).Cytochrome P450 1B1 and catechol-O-methyltransferase genetic polymorphisms and breast cancer risk in Chinese women: results from the shanghai breast cancer study and a meta-analysis. Cancer Epidemiol Biomarkers Prev 14, 329-335. (Pubitemid 40270093)
52. Wu, A.H., Yu, M.C., Tseng, C.C., and Pike, M.C. (2008).Epidemiology of soy exposures and breast cancer risk. Br J Cancer 98, 9-14.
53. Yao, L., Fang, F., Wu, Q., Zhong, Y., and Yu, L. (2010).No association between CYP1B1 Val432Leu polymorphism and breast cancer risk: a meta-analysis involving 40,303 subjects. Breast Cancer Res Treat 122, 237-242.
54. Zheng, W., Xie, D., Cerhan, J.R., Sellers, T.A., Wen, W., and Folsom, A.R. (2001).Sulfotransferase 1A1 polymorphism, endogenous estrogen exposure, well-done meat intake, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 10, 89-94. (Pubitemid 32172425)
55. Zheng, W., Xie, D., Jin, F., Cheng, J.R., Dai, Q., Wen, W.Q., Shu, X.O., and Gao, Y.T. (2000).Genetic polymorphism of cytochrome P4501B1 and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 9, 147-150. (Pubitemid 30111936)